Phase-II-study of efficacy of Osag 101 (Theraloc) [nimotuzumab] for adolescent patients with recurrent high grade glioma
Latest Information Update: 03 Nov 2020
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Glioma
- Focus Therapeutic Use
- Sponsors Oncoscience
- 04 Dec 2007 New trial record.